Pursuant to the Company’s 2025 Omnibus Equity Incentive Plan adopted and approved in 2025 (“2025 Plan”), awards under the 2025 Plan are limited in the aggregate to 2,000,000 shares of our common stock, inclusive of the awards that were previously issued and outstanding under the Company’s 2019 Omnibus Equity Incentive Plan,, as amended (the “2019 Plan”). Upon adoption and approval of the 2025 Plan, the 2019 Plan was frozen, no new awards will be granted under the 2019 Plan, and outstanding awards under the 2019 Plan will continue to be governed by the terms and condition of the 2019 Plan and applicable award agreement. As of June 30, 2026, the number of shares of the Company’s common stock available for grant of stock options and issuance under the 2025 Plan is 14,000 shares.

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. The risk free rate is based on the yield-to-maturity in continuous compounding of the US Government Bonds with the time-to-maturity similar to the expected tenor of the option granted, volatility is based on the annualized historical stock price volatility of the Company, and the expected life is based on the historical option exercise pattern.

For the six months ended June 30, 2026 and 2025, total compensation costs for options issued recorded in the consolidated statement of comprehensive income (loss) were nil. There were no related tax benefits as a full valuation allowance was recorded in the six-months ended June 30, 2026 and 2025.

The following table summarizes all Company stock option transactions between January 1, 2026 and June 30, 2026.

Stock Options and Warrants Outstanding and

Exercisable

Outstanding at

June 30, 2026

Range of

Exercise Prices

Weighted Average

Remaining

Contractual Life

(Years)

Outstanding and exercisable

—

All options exercisable and outstanding as at June 30, 2026 are fully vested. As of June 30, 2026 there was no unrecognized compensation cost related to outstanding stock options.

The aggregate intrinsic value of options outstanding and exercisable as of June 30, 2026, was nil.

During the six months ended June 30, 2026 and 2025, there were no options exercised.